JP2020519645A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020519645A5 JP2020519645A5 JP2019562579A JP2019562579A JP2020519645A5 JP 2020519645 A5 JP2020519645 A5 JP 2020519645A5 JP 2019562579 A JP2019562579 A JP 2019562579A JP 2019562579 A JP2019562579 A JP 2019562579A JP 2020519645 A5 JP2020519645 A5 JP 2020519645A5
- Authority
- JP
- Japan
- Prior art keywords
- hadsc
- pellet
- tissue
- adipose tissue
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762506006P | 2017-05-15 | 2017-05-15 | |
| US62/506,006 | 2017-05-15 | ||
| PCT/IL2018/050523 WO2018211498A1 (en) | 2017-05-15 | 2018-05-14 | Treatment of multiple sclerosis with adipose-derived stem cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020519645A JP2020519645A (ja) | 2020-07-02 |
| JP2020519645A5 true JP2020519645A5 (https=) | 2021-05-06 |
Family
ID=64274150
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019562579A Pending JP2020519645A (ja) | 2017-05-15 | 2018-05-14 | 脂肪組織由来幹細胞による多発性硬化症の治療 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US11510946B2 (https=) |
| EP (1) | EP3624816A4 (https=) |
| JP (1) | JP2020519645A (https=) |
| CN (1) | CN110573170A (https=) |
| AU (1) | AU2018270396B2 (https=) |
| CA (1) | CA3062123A1 (https=) |
| IL (1) | IL269893B2 (https=) |
| WO (1) | WO2018211498A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3624815A4 (en) | 2017-05-15 | 2021-01-20 | Stem Cell Medicine Ltd. | TREATMENT OF MULTIPLE SCLEROSIS WITH LONG-ACTING GLATIRAMER AND ADAPTIVE STEM CELLS |
| EP3624816A4 (en) | 2017-05-15 | 2021-02-24 | Stem Cell Medicine Ltd. | TREATMENT OF MULTIPLE SCLEROSIS WITH STEM CELLS DERIVED FROM ADIPOUS TISSUE |
| IL272145A (en) | 2020-01-20 | 2021-07-29 | Stem Cell Medicine Ltd | Cosmetic compositions with protein concentrate from conditioned medium of adipose-derived stem cells |
| CN115624571A (zh) * | 2022-12-21 | 2023-01-20 | 北京瑷格干细胞科技有限公司 | 人脂肪间充质干细胞在制备治疗硬皮病药物中的应用 |
| CN115624570A (zh) * | 2022-12-21 | 2023-01-20 | 北京瑷格干细胞科技有限公司 | 人脂肪间充质干细胞在制备治疗结缔组织疾病药物中的应用 |
Family Cites Families (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL36670A (en) | 1971-04-21 | 1974-09-10 | Sela M | Therapeutic basic copolymers of amino acids |
| IL113812A (en) | 1994-05-24 | 2000-06-29 | Yeda Res & Dev | Copolymer-1 pharmaceutical compositions containing it and its use |
| US6214791B1 (en) | 1997-01-10 | 2001-04-10 | Yeda Research And Development Co. Ltd. | Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1 |
| JP4328050B2 (ja) | 2000-01-20 | 2009-09-09 | イエダ リサーチ アンド デベロップメント カンパニー リミテッド | 神経保護療法のためのコポリマー１、関連ペプチド及びポリペプチドならびにそれらによって処理されたｔ細胞の使用 |
| US8871241B2 (en) | 2002-05-07 | 2014-10-28 | Psivida Us, Inc. | Injectable sustained release delivery devices |
| RU2339397C2 (ru) | 2003-01-21 | 2008-11-27 | Йеда Рисерч Энд Дивелопмент Ко.Лтд. | Сор1 для лечения воспалительных заболеваний кишечника |
| US7429378B2 (en) | 2003-05-13 | 2008-09-30 | Depuy Spine, Inc. | Transdiscal administration of high affinity anti-MMP inhibitors |
| ES2541780T3 (es) | 2004-11-29 | 2015-07-24 | Yeda Research And Development Co., Ltd. | Inducción de la neurogénesis y terapia con células madre en combinación con el Copolímero 1 |
| US20060165667A1 (en) | 2004-12-03 | 2006-07-27 | Case Western Reserve University | Novel methods, compositions and devices for inducing neovascularization |
| JP4654015B2 (ja) | 2004-12-08 | 2011-03-16 | 京セラ株式会社 | カメラ装置 |
| US20070003528A1 (en) | 2005-06-29 | 2007-01-04 | Paul Consigny | Intracoronary device and method of use thereof |
| DK1957633T3 (en) | 2005-10-13 | 2014-03-17 | Anthrogenesis Corp | Immunomodulation USING PLACE SPEECH STEM CELLS |
| EP1795588A1 (en) | 2005-12-07 | 2007-06-13 | Cellerix, S.L. | Use of adipose tissue derived mesenchymal stem cells for the treatment of graft versus host disease |
| WO2008024996A2 (en) | 2006-08-24 | 2008-02-28 | Johnstone Brian H | Production of neural protective and regenerative factors from stem cells and treatment of nervous system conditions therewith |
| ES2663875T3 (es) | 2006-11-03 | 2018-04-17 | Multiple Sclerosis Research Center Of New York | Células madre mesenquimáticas derivadas de la médula ósea como fuente de progenitores neurales |
| US8703180B1 (en) | 2007-10-23 | 2014-04-22 | Abbott Cardiovascular Systems Inc. | Multiple growth factor compositions, methods of fabrication, and methods of treatment |
| WO2009115581A2 (en) * | 2008-03-19 | 2009-09-24 | Cryo-Save Ag | Improved cryopreservation of adipose tissue for the isolation of mesenchymal stem cells |
| US20090291061A1 (en) | 2008-05-21 | 2009-11-26 | Riordan Neil H | Stem cell therapy for blood vessel degeneration |
| EP2620493B1 (en) | 2008-05-28 | 2019-03-27 | Ramot at Tel Aviv University Ltd. | Mesenchymal stem cells for the treatment of CNS diseases |
| US20110129450A1 (en) | 2008-08-01 | 2011-06-02 | Orly Lazarov | Method of promoting neurogenesis by modulating secretase activities |
| WO2010028051A2 (en) | 2008-09-03 | 2010-03-11 | Florida State University Research Foundation, Inc. | Substituted heterocyclic mercaptosulfonamide metalloprotease inhibitors |
| CN102186968A (zh) | 2008-10-17 | 2011-09-14 | 巴克斯特国际公司 | 从脂肪组织获得细胞群的方法 |
| JP5515319B2 (ja) | 2009-02-23 | 2014-06-11 | 富士レビオ株式会社 | 脂肪細胞への分化誘導培地及び方法 |
| EP3150703A1 (en) | 2009-07-09 | 2017-04-05 | TiGenix, S.A.U. | Cells for use in a method for treating inflammatory and/or immune disorders |
| US20120230966A1 (en) | 2009-09-30 | 2012-09-13 | Parcell Laboratories Llc | Tissue transplant compositions and methods for use |
| HUE060304T2 (hu) | 2010-01-04 | 2023-02-28 | Mapi Pharma Ltd | Glatiramer acetátot tartalmazó depó rendszer |
| US8377885B2 (en) | 2010-01-04 | 2013-02-19 | Mapi Pharma Ltd. | Depot systems comprising glatiramer or pharmacologically acceptable salt thereof |
| CA2790436A1 (en) | 2010-02-18 | 2011-08-25 | Osiris Therapeutics, Inc. | Immunocompatible chorionic membrane products |
| WO2012143924A1 (en) | 2011-04-21 | 2012-10-26 | Mapi Pharma Ltd. | Random pentapolymer for treatment of autoimmune diseases |
| US20130034524A1 (en) | 2011-08-03 | 2013-02-07 | Siamak Agha-Mohammadi | Non-Enzymatic Method for Harvesting Adipose-Derived Stromal Cells and Adipose-Derived Stem Cells from Fat and Lipo-Aspirate |
| EP2744892B1 (en) | 2011-09-23 | 2019-03-20 | Cell Ideas Pty Ltd. | Therapeutics using adipose cells and cell secretions |
| CL2011002642A1 (es) | 2011-10-24 | 2012-04-09 | Univ Del Desarrollo | Uso de una composicion formada por un glucocorticoide y una tiazolinediona que sirve para inducir la diferenciacion adipogenica en celulas madres. |
| EP2623110A1 (en) * | 2012-01-31 | 2013-08-07 | CSL Behring GmbH | Factor XII inhibitors for the treatment of neurological inflammatory disorders |
| SG11201405257WA (en) | 2012-03-12 | 2014-09-26 | Univ Singapore | Generation of brown adipose tissue (bat) from mesenchymal cells |
| CN104130975B (zh) * | 2013-05-03 | 2018-07-17 | 上海市东方医院 | 人源脂肪干细胞来源的神经元样细胞及其制备方法和应用 |
| US20150216908A1 (en) * | 2014-02-06 | 2015-08-06 | Steminent Biotherapeutics Inc. | Quadri-positive stromal cell (qpsc) population for superior cell protection and immunomodulation |
| US20170065638A1 (en) * | 2014-02-10 | 2017-03-09 | Cytori Therapeutics, Inc. | Regenerative cell therapy for central nervous system (cns) disorders and ptsd |
| US20190046576A1 (en) | 2016-02-12 | 2019-02-14 | Cell Care Therapeutics | Adipose tissue derived mesenchymal stromal cell conditioned media and methods of making and using the same |
| WO2018002930A1 (en) | 2016-06-30 | 2018-01-04 | Stem Cell Medicine Ltd. | Treatment of inflammatory bowel disease with long acting glatiramer and adipose-derived stem cells |
| EP3624816A4 (en) | 2017-05-15 | 2021-02-24 | Stem Cell Medicine Ltd. | TREATMENT OF MULTIPLE SCLEROSIS WITH STEM CELLS DERIVED FROM ADIPOUS TISSUE |
-
2018
- 2018-05-14 EP EP18801976.4A patent/EP3624816A4/en not_active Ceased
- 2018-05-14 JP JP2019562579A patent/JP2020519645A/ja active Pending
- 2018-05-14 IL IL269893A patent/IL269893B2/en unknown
- 2018-05-14 CN CN201880028213.1A patent/CN110573170A/zh active Pending
- 2018-05-14 US US16/613,369 patent/US11510946B2/en active Active
- 2018-05-14 AU AU2018270396A patent/AU2018270396B2/en active Active
- 2018-05-14 CA CA3062123A patent/CA3062123A1/en active Pending
- 2018-05-14 WO PCT/IL2018/050523 patent/WO2018211498A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020519645A5 (https=) | ||
| Sun et al. | Single-cell RNA-seq highlights heterogeneity in human primary Wharton’s jelly mesenchymal stem/stromal cells cultured in vitro | |
| Parekkadan et al. | Mesenchymal stem cells as therapeutics | |
| Nagamura-Inoue et al. | Umbilical cord-derived mesenchymal stem cells: their advantages and potential clinical utility | |
| Mildmay-White et al. | Cell surface markers on adipose-derived stem cells: a systematic review | |
| Sivasubramaniyan et al. | Phenotypic and functional heterogeneity of human bone marrow–and amnion‐derived MSC subsets | |
| Lee et al. | Double‐edged sword of mesenchymal stem cells: cancer‐promoting versus therapeutic potential | |
| Keating | Mesenchymal stromal cells: new directions | |
| Zhang et al. | Isolation and characterization of mesenchymal stem cells from whole human umbilical cord applying a single enzyme approach | |
| Lavoie et al. | Uncovering the secretes of mesenchymal stem cells | |
| Otsuru et al. | Improved isolation and expansion of bone marrow mesenchymal stromal cells using a novel marrow filter device | |
| Baer et al. | Adipose‐derived mesenchymal stromal/stem cells: tissue localization, characterization, and heterogeneity | |
| Phinney et al. | Mesenchymal stromal cells: misconceptions and evolving concepts | |
| Tong et al. | Generation of mesenchymal stem cell from human umbilical cord tissue using a combination enzymatic and mechanical disassociation method | |
| Goligorsky | Endothelial progenitor cells: from senescence to rejuvenation | |
| Patel et al. | Novel isolation strategy to deliver pure fetal-origin and maternal-origin mesenchymal stem cell (MSC) populations from human term placenta | |
| Bogdanova et al. | Characterization of human adipose-derived stem cells cultured in autologous serum after subsequent passaging and long term cryopreservation | |
| Fazzina et al. | A new standardized clinical‐grade protocol for banking human umbilical cord tissue cells | |
| Zhou et al. | Amniotic fluid-derived mesenchymal stem cells: characteristics and therapeutic applications | |
| US20240115618A1 (en) | Treatment of diseases of endothelial dysfunction and inflammation | |
| CN103421739B (zh) | 一种高效分离脐带间充质干细胞的方法 | |
| Chen et al. | The biological characteristics of sheep umbilical cord mesenchymal stem cells | |
| Hosseini et al. | Lupus mice derived mesenchymal stromal cells: Beneficial or detrimental on SLE disease outcome | |
| Li et al. | Immunomodulatory effects of mesenchymal stem cell therapy in chronic kidney disease: a literature review | |
| Jin et al. | Stem cell‐based cell therapy for glomerulonephritis |